Technical Trends Signal Caution
The downgrade is primarily driven by a change in the technical grade, which has shifted from bullish to mildly bullish. While some weekly indicators such as MACD and KST remain bullish, monthly signals have weakened, with MACD turning mildly bearish and RSI showing no clear signal. The daily moving averages continue to be bullish, but the mixed technical picture suggests a loss of momentum.
Bollinger Bands present a mildly bullish stance on the weekly chart and bullish on the monthly, yet the weekly RSI is bearish, indicating short-term selling pressure. Dow Theory assessments remain mildly bullish on both weekly and monthly timeframes, but the overall technical environment is less robust than before, prompting a more cautious stance.
At the current price of ₹134.15, the stock is trading near its 52-week high of ₹146.70 but has shown limited movement today, with a day’s low of ₹131.50. The technical downgrade reflects a nuanced view that while the stock is not in a full bearish phase, the bullish conviction has softened considerably.
Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.
- - New Reliable Performer
- - Steady quarterly gains
- - Fertilizers consistency
Valuation Improves but Does Not Offset Other Concerns
Interestingly, the valuation grade for Shree Hari Chemicals has improved from attractive to very attractive. The company’s price-to-earnings (PE) ratio stands at 20.56, which is considerably lower than many peers in the commodity chemicals industry. For instance, J.G. Chemicals trades at a PE of 29, while Titan Biotech and Nitta Gelatin are valued at 58.28 and 16.92 respectively, with Titan Biotech classified as very expensive.
Other valuation metrics reinforce this positive view. The enterprise value to EBITDA ratio is 16.74, and the EV to capital employed is a low 1.58, signalling that the stock is trading at a discount relative to its asset base and earnings potential. The company’s return on capital employed (ROCE) is modest at 6.07%, and return on equity (ROE) is 9.30%, which, while not stellar, supports the valuation attractiveness.
Despite these encouraging valuation metrics, the overall Mojo Score remains low at 47.0, with a Sell grade, reflecting that valuation alone is insufficient to warrant a positive rating given other weaknesses.
Financial Trends Show Mixed Signals
Financially, Shree Hari Chemicals has delivered flat performance in the latest quarter (Q4 FY25-26), with net sales declining by 7.5% to ₹41.22 crores compared to the previous quarter’s average. Non-operating income has surged to 161.72% of profit before tax, indicating reliance on non-core earnings to bolster profitability. This raises concerns about the sustainability of earnings quality.
The company’s half-year ROCE is at a low 9.50%, which is below industry averages and signals inefficient capital utilisation. Profitability has also been under pressure, with profits falling by 17.4% over the past year despite the stock generating a modest 3.15% return in the same period.
However, the long-term growth story remains intact. Net sales have grown at an annualised rate of 26.86%, and operating profit has expanded by 37.64% annually, reflecting underlying business strength. The stock has outperformed the BSE500 index over the last three years, delivering a remarkable 181.41% return compared to the index’s 17.79%.
Quality Assessment and Promoter Confidence
Quality metrics remain a concern, as reflected in the Mojo Grade downgrade from Hold to Sell. The company’s micro-cap status adds to the risk profile, with limited liquidity and higher volatility. Nevertheless, promoter confidence appears strong, with promoters increasing their stake by 5.01% in the previous quarter to hold 64.26% of the company. This stake increase is a positive signal, suggesting that insiders remain optimistic about the company’s future prospects despite recent challenges.
Comparing returns, Shree Hari Chemicals has outperformed the Sensex over multiple time horizons. Year-to-date, the stock has gained 2.40% while the Sensex declined by 8.56%. Over five years, the stock’s return of 82.52% surpasses the Sensex’s 48.19%, underscoring the company’s ability to generate shareholder value over the long term.
Holding Shree Hari Chemicals Export Ltd from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: A Cautious Stance Amid Mixed Signals
Shree Hari Chemicals Export Ltd’s downgrade to a Sell rating reflects a cautious stance amid mixed signals across key investment parameters. While valuation metrics have improved significantly, offering a very attractive entry point, technical indicators have softened and financial performance in the recent quarter has been flat to negative. The company’s reliance on non-operating income to support profits and low ROCE further weigh on the outlook.
Long-term growth trends and promoter confidence provide some reassurance, but the micro-cap nature of the stock and recent profit declines suggest investors should approach with caution. The current Mojo Score of 47.0 and Sell grade encapsulate this balanced view, signalling that despite pockets of strength, the risks currently outweigh the rewards.
Investors should closely monitor upcoming quarterly results and technical developments to reassess the stock’s trajectory. For now, a conservative approach is warranted given the combination of flat recent financials, mixed technical signals, and modest quality metrics.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
